Technical Comparison
NVIDIA Corporation - Common Stock vs Recursion Pharmaceuticals, Inc. - Class A Common Stock
Real-time financial comparison matrix between NVDA and RXRX.
Primary Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$217.94
Market Capitalization$5.3T
24h Change+0.90%
Circulating Supply24B NVDA
Comparison Asset
RXR
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Market Rank #1004267Live Price$4.05
Market Capitalization$2.4B
24h Change+6.58%
Circulating Supply597M RXRX
Market Metric Matrix
| Comparison Metric | NVDA Value | RXRX Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #101 | #1004267 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $217.94 | $4.05 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $5.3T | $2.4B | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is NVIDIA Corporation - Common Stock bigger than Recursion Pharmaceuticals, Inc. - Class A Common Stock?
NVIDIA Corporation - Common Stock has a market cap of $5.3T, while Recursion Pharmaceuticals, Inc. - Class A Common Stock sits at $2.4B. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between NVIDIA Corporation - Common Stock and Recursion Pharmaceuticals, Inc. - Class A Common Stock?
Currently, 1 NVDA is worth 53.81 RXRX.